Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lessons for human inflammatory bowel disease from experimental models.

A K Bhan1, E Mizoguchi, R N Smith

  • 1Department of Pathology, Immunopathology Unit, Massachusetts General Hospital, Boston, Massachusetts 02114, USA. abhan@partners.org

Current Opinion in Gastroenterology
|October 7, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Glycaemic control boosts glucosylated nanocarrier crossing the BBB into the brain.

Nature communications·2017
Same author

SU-E-I-91: Development of a Compact Radiographic Simulator Using Microsoft Kinect.

Medical physics·2017
Same author

TU-E-BRB-01: Similar-Case-Based Optimization of Beam Arrangements in Stereotactic Body Radiation Therapy.

Medical physics·2017
Same author

WE-G-BRCD-04: Development of Automated Determination Method of Robust Beam Directions against Patient Setup Errors Based on Spatial Distribution of Electron Density in Particle Therapy.

Medical physics·2017
Same author

SU-E-J-117: Computer-Assisted Verification of Accumulated Dose Distribution during the Treatment Time Based on Estimation of Four-Dimensional Dose Distribution Using an Electronic Portal Imaging Device.

Medical physics·2017
Same author

Interleukin-10-producing B-cells in autoimmune bullous diseases.

The British journal of dermatology·2017

New rodent models reveal that genetic factors and gut microbes drive inflammatory bowel disease (IBD) pathogenesis. Understanding CD4(+) T cell roles and cytokine imbalances offers new therapeutic strategies for IBD.

Area of Science:

  • Immunology
  • Gastroenterology
  • Microbiology

Background:

  • Inflammatory bowel disease (IBD) pathogenesis involves complex interactions between host genetics and the gut microbiome.
  • Mucosal immune responses are critical in IBD, with CD4(+) T cells playing a major pathogenic role.
  • Cytokine imbalances significantly influence the type and severity of intestinal injury in colitis.

Purpose of the Study:

  • To investigate the pathogenesis of chronic intestinal inflammation using novel rodent models.
  • To elucidate the role of genetic factors, enteric microflora, and CD4(+) T cells in IBD.
  • To explore the potential of immunoregulatory T cells and their secreted cytokines in IBD treatment.

Main Methods:

  • Utilized new rodent models to study chronic intestinal inflammation.

Related Experiment Videos

  • Analyzed the contribution of genetic factors and enteric microflora to mucosal immune responses.
  • Examined the function of CD4(+) T cells and cytokine networks in the development of colitis.

    • Main Results:

    • Identified genetic factors and enteric microflora as key regulators of pathogenic mucosal immune responses leading to colitis.
    • Confirmed CD4(+) T cells as major pathogenic cells, with injury type dependent on cytokine imbalance.
    • Demonstrated the suppressive role of cytokines like transforming growth factor-beta and interleukin-10.

    Conclusions:

    • Rodent models provide critical insights into human IBD pathogenesis.
    • The cytokine network orchestrated by CD4(+) T cells is pivotal in determining mucosal immune response outcomes.
    • Findings support the development of new therapeutic strategies for IBD targeting immunoregulatory pathways.